CVS Health Corp (CVS)

90.18
0.38 0.42
NYSE : Health Care
Prev Close 90.56
Open 90.31
Day Low/High 89.74 / 90.56
52 Wk Low/High 86.50 / 106.67
Volume 4.46M
Avg Volume 4.78M
Exchange NYSE
Shares Outstanding 1.07B
Market Cap 95.87B
EPS 4.70
P/E Ratio 20.77
Div & Yield 1.70 (1.90%)

Latest News

ELF Beauty Thinks Its Customers Have A Bottomless Makeup Bag

ELF Beauty Thinks Its Customers Have A Bottomless Makeup Bag

ELF Beauty is now officially a public company. Here is what the company's CEO has planned to keep the company's results looking sexy.

Will CVS Health (CVS) Stock Be Hurt by Delayed Curbside Service?

Will CVS Health (CVS) Stock Be Hurt by Delayed Curbside Service?

CVS Health (CVS) is putting its curbside delivery program on hold after the company's app was backlogged with orders, causing it to significantly slow down.

New Setback for Sanofi's Lantus Increases Need for M&A

New Setback for Sanofi's Lantus Increases Need for M&A

UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.

CVS Health Expands Youth Drug Abuse Prevention Efforts For The 2016-2017 School Year

CVS Health Expands Youth Drug Abuse Prevention Efforts For The 2016-2017 School Year

Company announces new partnership with DoSomething.org through its foundation and renews successful Pharmacists Teach prevention program

No Pressure From Retail Sales if Fed Wants to Delay Rate Hike

No Pressure From Retail Sales if Fed Wants to Delay Rate Hike

Sales dropped 0.3% in August, the Census Bureau said this morning, dragged lower by automobiles. That's not good news for banks like JPMorgan Chase hoping for higher interest rates.

CVS Health's ScriptSync® Service Marks One Year Anniversary

CVS Health's ScriptSync® Service Marks One Year Anniversary

With more than one million patients enrolled at the retail pharmacy, the service now expands to mail service pharmacy

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Washington

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Washington

Nearly 40 CVS Pharmacy locations in Washington can now dispense naloxone

CVS: A Good Name, But Is It a Good Price?

It doesn't seem a stretch to think CVS could rebound to $100 or better over the coming 12 months.

4 Cheap Pharma Stocks to Buy No Matter Who Is Elected

4 Cheap Pharma Stocks to Buy No Matter Who Is Elected

Greg Nathan, portfolio manager for the FPA U.S. Value Fund, is ignoring the clamor over drug pricing with these choices.

Ignore the Political Debate and Buy These 4 Cheap Pharma Stocks

Ignore the Political Debate and Buy These 4 Cheap Pharma Stocks

McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.

CVS Health Announces National Support Of YMCA Of The USA Diabetes Prevention Program And LIVESTRONG Foundation Initiatives

CVS Health Announces National Support Of YMCA Of The USA Diabetes Prevention Program And LIVESTRONG Foundation Initiatives

$225,000 investment expands programming at twenty YMCA Chapters

Trifecta Stocks Weekly Roundup

Most of the portfolio got caught in this week's downdraft, though we used weakness to add to our position in Sherwin-Williams.

These 5 Blue Chips Are Breaking Out

These 5 Blue Chips Are Breaking Out

Here's a technical look at how to trade some of the biggest stocks on the market right now.

CVS Health Increasing Access to Health Care with Annual Project Health Campaign

CVS Health Increasing Access to Health Care with Annual Project Health Campaign

Free wellness events have delivered more than $112 million worth of health services over the past decade

CVS Health to Host Third Annual In-Store Campaign to Support Innovative Cancer Research

CVS Health to Host Third Annual In-Store Campaign to Support Innovative Cancer Research

Customers can support Stand Up To Cancer's groundbreaking cancer research with a donation at the register at CVS Pharmacy locations nationwide

Trifecta Stocks Weekly Roundup

We added no positions this week, although we scaled up our position sizes in both Costco Wholesale and United Parcel Service.

Weekly Roundup: What the EpiPen Controversy Could Mean for U.S. Health Care

And how to play the fallout on related stocks.

CVS Drop Presents Yet Another Buying Chance

Momentum indicators are down hard, so is relative strength, while earnings were great.

Trifecta Stocks Weekly Roundup

We eliminated our position in Fortive but bulked up our stakes in recent newbies Sherwin-Williams and Whirlpool and added Nike to the portfolio.

Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco

Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco

Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.

22 Embarrassing Photos From Kmart's New York City Stores Explain Sears Financial Tailspin

22 Embarrassing Photos From Kmart's New York City Stores Explain Sears Financial Tailspin

Sears should be embarrassed by the state of its New York City stores.

Here's How to Trade CVS After Its Breakdown

Here's How to Trade CVS After Its Breakdown

As Thursday's breakdown develops, CVS will face a very important test.

Target: Expect More, Pay Less for Its Stock

Target: Expect More, Pay Less for Its Stock

The retailer's recent price weakness is an opportunity for investors to act.

Here's Why CVS Health (CVS) Stock Is Slipping Today

Here's Why CVS Health (CVS) Stock Is Slipping Today

CVS stock is under pressure on Thursday after Mylan (MYL) said it would cut the cost of its EpiPen, which could hit the pharmacy's bottom line.

CVS Health And Easterseals Celebrate Ten Years Of Partnership To Support Our Nation's Young Children On Their Path To Better Health

CVS Health And Easterseals Celebrate Ten Years Of Partnership To Support Our Nation's Young Children On Their Path To Better Health

Investment assures families have access to Easterseals' early childhood services nationwide

CVS Has a Prescription for Profit

CVS Has a Prescription for Profit

The stock has the potential for a breakout move.

CVS Health Research Institute Study Shows Value In Tailoring Medication Adherence Interventions To Specific Patient Populations

CVS Health Research Institute Study Shows Value In Tailoring Medication Adherence Interventions To Specific Patient Populations

Interventions focused on keeping patients adherent as well as those focused on patients with three or more chronic conditions can result in significant cost savings